Acquisition of an ibright FL1500 imaging system

Ended Purchase Order Awarded

Contract number
75N92021P00337
Awardee
Awarding agency
Obligated
$32,985

Award facts

Contract value 100% obligated
$32,985.00 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Funding agency
National Insititue of Arthritis and Musculoskeletal and Skin Diseases National Institutes of Health, Department of Health and Human Services
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Grand Island, NY 14072, USA

Award details come from SAM.gov/FPDS.

About this award

On September 24, 2021, the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a firm fixed-price purchase order valued at approximately $33K to Life Technologies Corporation, operating as Thermo Fisher Scientific, for the acquisition of an iBright FL1500 imaging system. The contract was completed on September 23, 2023, with performance taking place in Grand Island, New York. No set-aside designation was applied to this procurement. Life Technologies Corporation, a leading manufacturer of scientific instruments and reagents headquartered in Carlsbad, California, is well-positioned to support NIAMS's research infrastructure needs through its extensive portfolio of advanced biotechnology equipment and services across federal agencies.

The iBright FL1500 imaging system represents a fluorescence imaging platform commonly used in research settings for cell and tissue visualization applications, supporting NIAMS's mission in musculoskeletal and dermatological research. Life Technologies' parent company, Thermo Electron Corporation, maintains established relationships across the federal research community and holds multiple indefinite delivery vehicles with agencies including the Food and Drug Administration and Department of Veterans Affairs, reflecting the company's competitive positioning in supplying specialized laboratory instrumentation to federal agencies without set-aside restrictions.

Quick answers

Who was awarded contract 75N92021P00337?

75N92021P00337 was awarded to Life Technologies Corporation by National Heart Lung and Blood Institute (National Institutes of Health) on September 24, 2021.

How much is contract 75N92021P00337 worth?

The government has obligated $32,985 on 75N92021P00337.

Which agency awarded contract 75N92021P00337?

National Heart Lung and Blood Institute (National Institutes of Health) awarded 75N92021P00337, with funding from National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health).

Was contract 75N92021P00337 competed?

The extent of competition for 75N92021P00337 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award